Yamanouchi describes SAR leading to YM-60828, a potent and selective factor Xa inhibitor Dec. 11, 1997 No Comments
Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration Dec. 2, 1997 No Comments
RSS